Skip to Content
Biotechnology

CRISPR creates new species with single giant chromosome

For at least the last 10 million years every yeast cell of the sort used to make beer or bread has had 16 chromosomes. But now—thanks to CRISPR technology and some DNA tinkerers in China—there are living yeast with just one.

Genome organizer: We humans have our genes arranged on 46 chromosomes, yeast use 16, and there’s even a fern plant with 1260 of them. That’s just the way it is. And no one is quite sure why.

The big one: Do we really need so many chromosomes? That’s what Zhogjun Qin and colleagues at the Key Laboratory of Synthetic Biology in Shanghai wanted to know.

With CRISPR, the gene-editing tool, Qin’s team chopped out the button-like centromeres that hold each stringy chromosome together, and then started fusing them into one long chain. The result: organisms with eight, four, two, and even finally just one “single giant chromosome.”

Is this a new species? Good question. Yeast with fewer chromosomes can’t mate very well or at all with regular ones, but they did fine with their own numerical kind. This may indeed be the start of a separate, man-made species.

What it’s for: Scientists want to explore why cells have chromosomes at all, so the weird new yeast could help. But the work is also a demonstration of “large-scale genome engineering,” say the Chinese team in their report, which appeared in the scholarly journal Nature. 

The ultimate goal of these experiments? Using technology to create useful, human-designed life forms of kinds never seen before.

Deep Dive

Biotechnology

The first babies conceived with a sperm-injecting robot have been born

Meet the startups trying to engineer a desktop fertility machine.

Doctors have performed brain surgery on a fetus in one of the first operations of its kind

A baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old.

A brain implant changed her life. Then it was removed against her will.

Her case highlights why we need to enshrine neuro rights in law.

The FDA just approved rub-on gene therapy that helps “butterfly” children

Biotech companies are getting creative with how they deliver DNA fixes into people's bodies.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.